Third Sartorius Research Xchange Forum 2019 focuses on CAR-T cell therapy

13 Mar 2019

Event for experts from academia and industry, including talks, live demo sessions, and panel discussion.

Promoting interdisciplinary exchange and fostering potential collaborations between academia and industry on highly promising scientific fields relevant to both scientists and businesses is the objective of Sartorius in hosting its third Research Xchange Forum (RXF2019) on 25 April 2019, which will spotlight CAR-T cell therapy.

Third Sartorius Research Xchange Forum 2019 focuses on CAR-T cell therapy

The forum is being organized in collaboration with Science/AAAS. The American Association for the Advancement of Science (AAAS) is the world’s largest general scientific society, and the forum will be held at the AAAS headquarters in Washington DC. Experts from the academic, clinical and biotech sectors will offer insights on novel developments in CAR-T cell therapies.

Guest speakers will include Prof. Bruce Levine (University of Pennsylvania), Rick Morgan, Sr. VP Immunogenetics (Editas Medicine), and others from institutions such as UCLA, Boston University, MD Anderson Cancer Center, Horizon Discovery, Colorado State University, MaSTherCell and St Jude Children's Research Hospital.

The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy will be awarded in an invitation-only post-event ceremony. Sartorius and Science/AAAS aim to recognize outstanding research contributions made in the regenerative medicine and cell therapy fields by the next generation of young scientists, the next thought leaders shaping our future as a society.

Read More

Related news

Envigo launches PATHWAY to enable FIH clinical trials

Envigo launches PATHWAY to enable FIH clinical trials

11 Mar 2019

PATHWAY manages the complexity of the entire safety assessment process on behalf of the company’s pharmaceutical and biotechnology customers.

Read more 
Biogen acquisition boosts its ophthalmology pipeline

Biogen acquisition boosts its ophthalmology pipeline

4 Mar 2019

Nightstar Therapeutics has two potentially first-in-class mid- to late-stage clinical assets as well as preclinical programs.

Read more 
Uniqsis expands LED photoreactor range

Uniqsis expands LED photoreactor range

3 Mar 2019

The availability of three new alternative switchable LED configurations provides chemists with the unique ability to optimally undertake almost any photochemistry reaction.

Read more 
Crowdfund and discover promising therapeutics via Molecule

Crowdfund and discover promising therapeutics via Molecule

21 Feb 2019

Connecting scientists, patients, and industry to advance drug development in a collaborative open market.

Read more 
Partnership expands to develop a new treatment for pachyonychia congenita

Partnership expands to develop a new treatment for pachyonychia congenita

19 Feb 2019

MedPharm and Palvella Therapeutics hope to develop the first approved treatment for PC in the US and Europe.

Read more 
Chemspace and LabNetwork collaborate to extend access to chemical databases

Chemspace and LabNetwork collaborate to extend access to chemical databases

14 Feb 2019

Collaboration provides drug discovery researchers access to European distribution and local support for library of in-stock and on-demand compounds.

Read more 
SGS to conduct its first malaria human challenge trial in Belgium

SGS to conduct its first malaria human challenge trial in Belgium

13 Feb 2019

The advanced candidate compound undergoing the trial has demonstrated potential to target malaria parasites before they have a chance to establish the symptoms of malaria.

Read more 
New API screening program strengthens Particle Sciences' nanomilling offering

New API screening program strengthens Particle Sciences' nanomilling offering

22 Jan 2019

Advanced formulation techniques such as nanomilling may provide an excellent route to improved bioavailability and enhanced therapeutic effect.

Read more 
Preparing samples of cannabis plant for THC/CBD analysis

Preparing samples of cannabis plant for THC/CBD analysis

15 Jan 2019

Porvair Sciences has created a solid, stable and strong microplate that can withstand the applied forces in bead-beaters while maintaining a standard ANSI/SLAS footprint and key dimensions.

Read more 
Allergan to establish R&D presence in Cambridge, Massachusetts

Allergan to establish R&D presence in Cambridge, Massachusetts

10 Jan 2019

The new, strategic presence will allow the company to more easily interact and engage with venture firms and start ups in the area.

Read more